FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to hematology oncology, and is intended to predict the development of recurrence of diffuse large B-cell lymphoma. In the peripheral blood of patients at the stages of examination after or before the next course of anticancer therapy, a general blood test is performed, the content of red and white blood elements is determined, and the ratio of neutrophils to lymphocytes (N/L) is calculated. If the value of the ratio N/L ≤ 1.9, remission is predicted. If the value of the ratio N/L ≥ 3.0, recurrence of the process is predicted within 6-10 months.
EFFECT: invention provides the development of a method for predicting the development of recurrence of diffuse large B-cell lymphoma.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING EFFECTIVENESS OF THERAPY OF HODGKIN'S LYMPHOMA IN PUBERTAL BOYS | 2024 |
|
RU2840699C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTIC OF HODGKIN'S LYMPHOMA AND LYMPHADENITIS IN ADOLESCENTS | 2015 |
|
RU2599100C1 |
| METHOD FOR PREDICTING THE COURSE OF PRIMARY MEDIASTINAL B-LARGE CELL LYMPHOMA | 2021 |
|
RU2772187C1 |
| METHOD OF DETERMINING ACTIVITY OF TUBERCULOUS PROCESS IN CASE OF PNEUMOCONIOSIS | 0 |
|
SU1394139A1 |
| METHOD OF ESTIMATING CLINICAL EFFECTIVENESS IN CHRONIC MYELOID LEUKEMIA | 2012 |
|
RU2495430C1 |
| METHOD OF ASSAY OF MALIGNANT NEOPLASM SIZE AND COUNT OF MALIGNANT CELLS IN PATIENT BODY | 1995 |
|
RU2135996C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF LYMPHADENOPATHIES OF DIFFERENT GENESIS IN CHILDREN | 2004 |
|
RU2268474C1 |
| METHOD FOR DIAGNOSING MALIGNANT NEOPLASM METASTASES IN REGIONAL LYMPHATIC NODES | 1995 |
|
RU2131606C1 |
| METHOD OF DIFFERENTIAL DIAGNOSING OF CANCER AND PRECANCER PATHOLOGY | 1992 |
|
RU2045072C1 |
| METHOD FOR SETTING DIFFERENTIAL DIAGNOSIS OF MALIGNANT NEOPLASM AND BENIGN PATHOLOGIC FORMATIONS | 1994 |
|
RU2114431C1 |
